2025-11-17T05:40:40-08:00 2024-12-31 942861940 BREGANTE COMPANY LLP CPAS 50 CALIFORNIA STREET SUITE 1500 SAN FRANCISCO CA 94111 990 2024-01-01 992133246 HOLOBIONT MEDICAL RESEARCH FOUNDATION HOLO 4152233901 953 INDIANA STREET SAN FRANCISCO CA 94107 LARRY WEISS President 2025-11-17 true true Jennifer L Ruth P00854240 4157771001 2024 2025-03-06 01:10:19Z X LARRY WEISS 953 INDIANA STREET SAN FRANCISCO CA 94107 335001 false X WWW.HOLOBIO.ORG X 2024 CA THE HOLOBIONT MEDICAL RESEARCH FOUNDATION IS DEDICATED TO ADVANCING SCIENTIFIC KNOWLEDGE AND IMPROVING HUMAN HEALTH THROUGH RESEARCH AND INNOVATION. OUR MISSION IS TO UNRAVEL THE INTRICATE CONNECTIONS BETWEEN THE HUMAN MICROBIOME, EXPOSOME AND PHYSIOLOGICAL PROCESSES WITHIN THE HUMAN BODY THAT DEFINE HEALTH AND WELL-BEING. 5 3 0 0 335000 0 1 0 335001 301770 0 0 0 16000 24018 325788 9213 9213 0 9213 THE HOLOBIONT MEDICAL RESEARCH FOUNDATION IS DEDICATED TO ADVANCING SCIENTIFIC KNOWLEDGE AND IMPROVING HUMAN HEALTH THROUGH RESEARCH AND INNOVATION. OUR MISSION IS TO UNRAVEL THE INTRICATE CONNECTIONS BETWEEN THE HUMAN MICROBIOME, EXPOSOME AND PHYSIOLOGICAL PROCESSES WITHIN THE HUMAN BODY THAT DEFINE HEALTH AND WELL-BEING. false false 301770 301770 Grant funding supports early stage translational research in skin microbiome science. Through these grants, the organizations conducted laboratory and analytical work to characterize microbial-derived metabolites, postbiotic compounds and host inflammatory responses. The funding supported development of experimental models, baseline assays and data collection aimed at improving understanding of human-microbe interactions relevant to dermatologic and immunologic health. The work establishes foundational evidence needed for future clinical investigation and public-benefit applications. Grant funds also enabled the design and preliminary validation of protocols, measurement tools, and digital processes to support decentralized, community-engaged clinical research related to skin and muscosal health. Activities included drafting research protocols, refining remote data-collection workflows, establishing microbiome samplign and handling methods, and preparing study materials suitable for future IRB submission. 301770 true true false false false false false false false false false false false false false false false false false false false false false false false false false true false false false false false false true false false false false false false false false false false false false true 0 0 false 0 false false false false false false false 0 false false false false false false false X 5 3 true false false false false false false true true false false true false false false false false false CA X LARRY WEISS 4158128600 79 RIVERTON DRIVE SAN FRANCISCO CA 94132 X LARRY WEISS President 2.00 0.00 X 0 0 0 JULIA DURACK Vice President 1.00 0.00 X 0 0 0 CARLOS BUSTAMANTE Secretary 1.00 0.00 X 0 0 0 RITA COLWELL Treasurer 1.00 0.00 X 0 0 0 HOWARD MAIBACH Director 1.00 0.00 X 0 0 0 0 false false false 0 335000 335000 0 1 1 0 0 0 0 0 0 0 0 335001 1 301770 301770 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1352 1352 0 4715 4715 0 0 0 1045 1045 0 0 0 0 0 0 GRANT WRITING 16000 16000 ADMINISTRATIVE SERVICES 906 906 0 325788 301770 8018 16000 3613 5600 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9213 0 0 X 9213 0 9213 0 9213 9213 X false false false X 335000 335000 0 0 0 0 335000 335000 0 0 335000 1 1 0 1 1 0 0 335001 335001 X 0.00000 0.00000 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false BIOMEMIMETICS LLC 2325 - 3RD ST STE 223 SAN FRANCISCO CA 94107 331273762 51000 0 MEDICAL RESEARCH WEISS BIOSCIENCE INC 953 INDIANA ST SAN FRANCISCO CA 94107 873280575 250770 0 MEDICAL RESEARCH 0 2 LARRY WEISS 50% OWNER BIOMEMIMETICS 25500 CASH GRANTS MEDICAL RESEARCH JULIA DURACK 50% OWNER BIOMEMIMETICS 25500 CASH GRANTS MEDICAL RESEARCH Form 990, Part VI, Section A, Line 2 LARRY WEISS AND JULIA DURACK ARE 50/50 MEMBERS IN BIOMEMIMETICS, LLC. Form 990, Part VI, Section B, Line 11b A draft of the return is provided to the Board of Directors for review. Each director is given an opportunity to ask questions and request revisions before the return is finalized and filed. Form 990, Part VI, Section C, Line 19 No documents available to the public.